TLDR
- Barclays moved Nike (NKE) to overweight, increasing its price target from $64 to $73
- NKE shares have declined approximately 25% over the trailing 12 months, trading near decade lows
- North America revenue climbed 9% in the latest quarter, though net income dropped 31% year-over-year
- The company releases Q3 FY2026 results on March 31, representing a pivotal moment for recovery prospects
- Barclays suggests investor sentiment appears to have reached “peak skepticism”
Nike has endured a challenging period. Shares have fallen approximately 25% during the past year, trading near their lowest levels in a decade — a difficult position for one of the world’s most iconic brands.
The athletic apparel giant faces multiple challenges simultaneously. Revenue growth has slowed, pressure from established and emerging competitors continues mounting, and leadership changes have introduced additional uncertainty. Factor in tariff concerns and cautious consumer behavior, and the investment case becomes difficult to embrace — though that perspective may be shifting.
On Monday, Barclays elevated NKE to overweight while raising its price target to $73 from $64. The investment firm highlighted operational improvements, strengthening financials, and more focused management as early indicators that Nike is making progress toward recovery.
Barclays offered an additional observation, suggesting the market appears to have hit “peak skepticism” on the stock — implying conditions may stabilize from current levels.
North America Shows Strength While Profitability Lags
The financial picture presents contrasts. During its latest quarter, Nike’s North America division delivered 9% sales growth, while the past six months showed 6% gains in that market. These figures represent encouraging developments.
Profitability tells a different story. Net income across the most recent two quarters totaled $1.5 billion, representing a 31% decline compared to the prior year. Elevated costs continue to offset revenue gains the company manages to achieve.
This disconnect between revenue growth and profit performance explains why many investors remain hesitant about the stock.
March 31 Represents Critical Milestone
Nike faces an important evaluation point with its Q3 FY2026 earnings announcement scheduled for March 31. The company will be reporting results against softer figures from the corresponding period last year, potentially creating favorable year-over-year comparisons.
Whether these figures reflect authentic momentum remains uncertain. Some analysts believe the conditions could produce results exceeding expectations. Others highlight persistent macro challenges — consumers shifting toward lower-priced alternatives, tariff implications — as justification for maintaining caution.
The Barclays upgrade comes with caveats. The firm recognized Nike still carries risk. The assessment does indicate that current pricing may already reflect anticipated difficulties.
Shares currently trade near their lowest points in ten years. Some view this as a troubling signal. Others interpret it as an opportunity for a rebound.
Nike announces earnings on March 31.
